As first reported by Med-Tech Insights, the UK Government has announced a £1 million investment to expand the Medicines and Healthcare products Regulatory Agency’s (MHRA) AI Airlock programme. This pioneering initiative offers AI developers a first-of-its-kind regulatory ‘sandbox’ environment to test medical devices in collaboration with regulators before they enter the healthcare system. The expansion is intended to accelerate the responsible use of AI in medicine while safeguarding patient safety.
Successful pilot paves way for broader rollout
Following a successful initial phase that tested four groundbreaking technologies—including tools for personalized cancer treatment and real-time AI performance monitoring—the programme is now accepting applications for its second cohort. Launched on June 23, 2025, the new round invites developers of promising AI devices that pose novel regulatory questions and offer measurable benefits to patients and the NHS.
Strategic support for safe AI adoption
The initiative aligns with broader UK Government commitments laid out in the AI Opportunities Action Plan and the Regulatory Horizons Council’s recommendations. By enhancing regulators’ capacity to assess AI-driven solutions, the programme aims to balance rapid innovation with rigorous safety checks. According to Science Minister Lord Vallance, the Airlock will help “cut red tape” while delivering safe, efficient care and easing NHS pressures.
Positioning the UK as a global AI healthcare leader
Health Minister Baroness Merron emphasized the potential of AI to transform healthcare delivery, adding that the new funding would support thorough yet agile evaluation processes. The programme is positioned as a strategic lever in strengthening the UK’s global leadership in digital health innovation.
With a significant funding increase and a growing pool of applicants, the MHRA’s AI Airlock programme represents a bold step toward integrating AI into patient care in a safe and timely manner. By fostering close collaboration between developers and regulators, the UK is setting a strong precedent for responsible AI deployment in global healthcare.
